Pharmafile Logo

Ceftobiprole

- PMLiVE

Basilea moves closer to US filing of novel antibiotic

Analysts expect US launch in 2022

Can Cinderella save us?

Basilea bags $72m upfront from Pfizer for antifungal license

Pfizer will also pay $427m in future milestone payments for Cresemba

Can Cinderella save us?

Basilea’s novel antibiotic reaches UK market

Zevtera can be used against a range of infections including MRSA

- PMLiVE

FDA panel backs new antifungal Cresemba

Basilea/Astellas drug tipped to become a $500m product

Basilea appoints commercial head

David Veitch spent 15 years at BMS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links